93 related articles for article (PubMed ID: 26657726)
1. Interleukin-19 and angiopoietin-2 can enhance angiogenesis of diabetic complications.
Li L; Yu ZH; Qian L; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
J Diabetes Complications; 2016 Mar; 30(2):386-7. PubMed ID: 26657726
[TBL] [Abstract][Full Text] [Related]
2. Association between interleukin-19 and angiopoietin-2 with vascular complications in type 2 diabetes.
Li L; ZHeng-Qing Y; Juan-Yu H; Jian-Yong X; Fan L; Guang-Chun Z; Lei Z; Hui-Ming G; Si-Jing Z; Meng J
J Diabetes Investig; 2016 Nov; 7(6):895-900. PubMed ID: 27182008
[TBL] [Abstract][Full Text] [Related]
3. Serum angiopoietin-2 is associated with angiopathy in type 2 diabetes mellitus.
Li L; Qian L; Yu ZQ
J Diabetes Complications; 2015; 29(4):568-71. PubMed ID: 25754501
[TBL] [Abstract][Full Text] [Related]
4. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
[TBL] [Abstract][Full Text] [Related]
5. The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications.
Zorena K; Jachimowicz-Duda O; Wąż P
Biomarkers; 2016; 21(3):276-82. PubMed ID: 26849008
[TBL] [Abstract][Full Text] [Related]
6. [Role of circulating angiogenic factors in diabetic kidney disease].
Martynov SA; Shestakova MV; Kutyrina IM; Il'in AV; Arbuzova MI; Dedov II
Vestn Ross Akad Med Nauk; 2013; (2):35-42. PubMed ID: 23819327
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Lim HS; Lip GY; Blann AD
Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of angiopoietin-2, but not angiopoietin-1, are elevated in patients with erythrodermic cutaneous T-cell lymphoma.
Kawaguchi M; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2014 Jan; 94(1):9-13. PubMed ID: 23817541
[TBL] [Abstract][Full Text] [Related]
9. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study.
Rasul S; Reiter MH; Ilhan A; Lampichler K; Wagner L; Kautzky-Willer A
Cardiovasc Diabetol; 2011 Jun; 10():55. PubMed ID: 21699724
[TBL] [Abstract][Full Text] [Related]
10. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.
Belloni D; Marcatti M; Ponzoni M; Ciceri F; Veschini L; Corti A; Caligaris Cappio F; Ferrarini M; Ferrero E
Exp Cell Res; 2015 Jan; 330(1):1-12. PubMed ID: 25447443
[TBL] [Abstract][Full Text] [Related]
12. Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.
Alexandrakis MG; Pappa CA; Kokonozaki M; Boula A; Vyzoukaki R; Staphylaki D; Papadopoulou A; Androulakis N; Tsirakis G; Sfiridaki A
Med Oncol; 2015 Mar; 32(3):42. PubMed ID: 25631632
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes.
Wu W; Wang M; Sun Z; Wang X; Miao J; Zheng Z
Acta Diabetol; 2012 Feb; 49(1):3-7. PubMed ID: 20495833
[TBL] [Abstract][Full Text] [Related]
14. Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes.
Nomura S; Shouzu A; Omoto S; Inami N; Ueba T; Urase F; Maeda Y
J Atheroscler Thromb; 2009 Apr; 16(2):83-90. PubMed ID: 19403992
[TBL] [Abstract][Full Text] [Related]
15. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
[TBL] [Abstract][Full Text] [Related]
17. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.
Naumnik W; Chyczewska E; Ossolinska M
Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656
[TBL] [Abstract][Full Text] [Related]
19. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor-Alpha and 8-Hydroxy-2'-Deoxyguanosine are Associated with Elevated Urinary Angiopoietin-2 Level in Type 2 Diabetic Patients with Albuminuria.
He FF; Li HQ; Huang QX; Wang QY; Jiang HJ; Chen S; Su H; Zhang C; Wang YM
Kidney Blood Press Res; 2015; 40(4):355-65. PubMed ID: 26160410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
